Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Myeloid 1CNS 1

Conditions

Neoplasms 2Thrombocythemia, Essential 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pinealoma 1Pancreatic Cancer Metastatic 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Myeloproliferative Disorders 1Medulloblastoma 1Leukemia, Myelomonocytic, Chronic 1Histiocytosis, Langerhans-Cell 1Ependymoma 1Carcinoma 1Brain Neoplasms 1

Interventions

etoposide phosphate 1Sirolimus 1Etoposide 1Cyclophosphamide 1Celecoxib 1Automobiles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pinealoma × Celecoxib × Clear all
NCT02574728 2026-03-02

AflacST1502

Emory University

Phase 2 Active not recruiting
46 enrolled
CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡